17 results on '"Long term safety"'
Search Results
2. P.7.d.013 Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
3. P.2.c.010 The multimodal antidepressant Lu AA21004: open-label long-term safety and tolerability study in major depressive disorder
4. P.2.c.023 Long-term safety and tolerability of the multimodal antidepressant Lu AA21004 in subjects with major depressive disorder
5. P.3.c.046 Long-term safety and maintenance of effect of asenapine in patients with acute exacerbation of schizophrenia
6. P.2.d.024 Long-term safety and tolerability of open-label cariprazine in patients with bipolar I disorder
7. P.2.b.011 Vortioxetine (Lu AA21004) 15 and 20 mg/day: open-label long-term safety and tolerability in major depressive disorder
8. P.1.i.038 Long-term safety and efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
9. P.7.a.002 A long-term safety study of prolonged-release methylphenidate in adults with ADHD
10. P.5.a.006 Long-term safety and tolerability of memantine: an open-label extension study in patients with mild to moderate Alzheimer's disease
11. S.10.05 European guidelines: long-term safety of medication
12. P.2.023 A multi-center, one year, haloperidol controlled trial assessing the long term safety, efficacy and quality of life of sertindole in stable schizophrenic patients
13. Two open-label, long-term safety studies of sertindole
14. Long-term safety upon switching from daily SSRIs to fluoxetine once-weekly
15. Long-term safety of risperidone
16. P-46 Paroxetine long-term safety and efficacy in panic disorder and prevention of relapse: A double blind study
17. P-4-70 Two open-label, long-term safety studies of sertindole
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.